EC Orthopaedics

Background: Osteoarthritis (OA) is a degenerative joint disease that affect different parts of a synovial joint leading to pain and stiffness.

Methods: Forty male rats (220 ± 20g, aged 10 - 12 weeks), were randomly divided into eight groups (n = 8).

OA: Anterior cruciate ligament transection (ACLT) + PBS.

OA+ Hyaluronic acid (HA): ACLT+ treatment with HA.

OA+ Captopril (Cap): ACLT + treatment with Cap.

OA+ Losartan (Los): ACLT + treatment with Los.

OA+ Wharton-jelly mesenchymal stem cell conditioned medium (WJ): ACLT + treatment with WJ.

OA+ WJ+ Cap.: ACLT + treatment with WJ.

OA+ WJ+ Los.: ACLT + treatment with WJ and losartan.

Sham: No ACLT+ PBS.

Osteoarthritis was induced through transection of the anterior cruciate ligament of both knees in rats. Three months after treatment, the samples were harvested and evaluated by histopathological, radiological and ACE activity analyses.

Result: Histopathological and radiological findings indicated significant differences between the WJ+Cap and WJ+Los treated groups with OA+Cap OA+Los, the control and OA+HA groups (p ≤ 0:001). Significant differences were observed in the subchondral bone scores between WJ-CM+Cap, WJ+Los and WJ groups and OA+Cap, OA+Los, OA+HA groups (p ≤ 0:001). compared to WJ group alone, co-treatment of WJ and renin-angiotensin system (RAS) inhibitors (WJ+Cap and WJ+Los) showed better results regarding matrix scores (p ≤ 0:001).

Conclusion: The group treated with WJ concomitant with RAS inhibitor drugs showed better outcomes than other groups in histopathological, radiological and angiotensin converting enzyme (ACE) activity evaluation.

Keywords: Osteoarthritis; Mesenchymal Stem Cell; Conditioned Medium; Captopril; Losartan

1. Berenbaum FJO. cartilage. “Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)”. 21.1 (2013): 16-21.
2. Buckwalter J and Mankin HJIcl. “Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation”. 47 (1998): 487-504.
3. Cross M., et al. “The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study”. 73.7 (2014): 1323-1330.
4. Lopez-Sublet M., et al. “Focus on increased serum angiotensin-converting enzyme level: From granulomatous diseases to genetic mutations”. Clinical Biochemistry 59 (2018): 1-8.
5. Düsing R. “Pharmacological interventions into the renin–angiotensin system with ACE inhibitors and angiotensin II receptor antagonists: effects beyond blood pressure lowering”. Therapeutic Advances in Cardiovascular Disease3 (2016): 151-161.
6. Russo V., et al. “ACE inhibition to slow progression of myocardial fibrosis in muscular dystrophies”. Trends in Cardiovascular Medicine5 (2018): 330-337.
7. Charoo NA., et al. “Lesson learnt from recall of valsartan and other angiotensin II receptor blocker drugs containing NDMA and NDEA impurities”. 20.5 (2019): 166.
8. McCurdy MT., et al. “Angiotensin II: Time to Study Starting a Stopped Heart”. 47.5 (2019): e436.
9. Speretta GF., et al. “Importance of AT1 and AT2 receptors in the nucleus of the solitary tract in cardiovascular responses induced by a high-fat diet”. Hypertension Research4 (2019): 439-449.
10. Liu Q., et al. “Protective Effect of RA on Myocardial Infarction-Induced Cardiac Fibrosis via AT1R/p38 MAPK Pathway Signaling and Modulation of the ACE2/ACE Ratio”. Journal of Agricultural and Food Chemistry35 (2016): 6716-6722.
11. Nehme A., et al. “An update on the tissue renin angiotensin system and its role in physiology and pathology”. 6.2 (2019): 14.
12. Frantz EDC., et al. “Modulation of the renin–angiotensin system in white adipose tissue and skeletal muscle: focus on exercise training”. 132.14 (2018): 1487-1507.
13. Wang Y., et al. “The renin-angiotensin system in the synovium promotes periarticular osteopenia in a rat model of collagen-induced arthritis”. 65 (2018): 550-558.
14. MacKenzie A., et al. “Angiotensin II Type 1 receptor blockade protects endothelium-derived hyperpolarising factor-mediated relaxation in a rat model of monoarthritis”. 92.23 (2013): 1131-1137.
15. Ahmed AZ., et al. “Patterns of angiotensin converting enzyme insertion/deletion gene polymorphism among an Egyptian cohort of patients with rheumatoid arthritis”. 16.3 (2013): 284-290.
16. Hennig A., et al. “Feedback activation of neurofibromin terminates growth factor-induced Ras activation”. 14.1 (2016): 1-14.
17. Santos-Rocha J., et al. “Maternal high-sodium intake affects the offspring’ vascular renin-angiotensin system promoting endothelial dysfunction in rats”. 115 (2019): 33-45.
18. Gandhi CK., et al. “Degradation of lung protective angiotensin converting enzyme-2 by meconium in human alveolar epithelial cells: a potential pathogenic mechanism in meconium aspiration syndrome”. 197.2 (2019): 227-233.
19. Parrish JN., et al. “Estradiol modulation of the renin–angiotensin system and the regulation of fear extinction”. 9.1 (2019): 1-12.
20. Yamagishi K., et al. “Activation of the renin angiotensin system in mice aggravates mechanical loading induced knee osteoarthritis” 62.3 (2018).
21. Tang Y., et al. “Captopril, an angiotensin-converting enzyme inhibitor, possesses chondroprotective efficacy in a rat model of osteoarthritis through suppression local renin-angiotensin system”. 8.8 (2015): 12584.
22. Feng JE., et al. “Total knee arthroplasty: improving outcomes with a multidisciplinary approach”. 11 (2018): 63.
23. Mamidi MK., et al. “Mesenchymal stromal cells for cartilage repair in osteoarthritis”. 24.8 (2016): 1307-1316.
24. Da Silva Meirelles L., et al. “Mechanisms involved in the therapeutic properties of mesenchymal stem cells”. 20.5-6 (2009): 419-427.
25. Bruno S., et al. “Mesenchymal stem cell-derived microvesicles protect against acute tubular injury”. 20.5 (2009): 1053-1067.
26. Lai RC., et al. “Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury”. 4.3 (2010): 214-222.
27. Soleimanifar F., et al. “Adipose‐derived stem cells‐conditioned medium improved osteogenic differentiation of induced pluripotent stem cells when grown on polycaprolactone nanofibers”. 234.7 (2019): 10315-10323.
28. Liang H., et al. “Progress in the treatment of osteoarthritis with umbilical cord stem cells” (2020).
29. Famian MH., et al. “Conditioned medium of wharton's jelly derived stem cells can enhance the cartilage specific genes expression by chondrocytes in monolayer and mass culture systems”. 7.1 (2017): 123.
30. Widowati W., et al. “Effects of insulin-like growth factor-induced Wharton jelly mesenchymal stem cells toward chondrogenesis in an osteoarthritis model”. Iranian Journal of Basic Medical Sciences7 (2018): 745-752.
31. Kusuma HSW., et al. “Effect of Conditioned Medium from IGF1-Induced Human Wharton's Jelly Mesenchymal Stem Cells (IGF1-hWJMSCs-CM) on Osteoarthritis”. The Avicenna Journal of Medical Biotechnology3 (2020): 172-178.
32. Endrinaldi E., et al. “The effect of mesenchymal stem cell wharton’s jelly on matrix metalloproteinase-1 and interleukin-4 levels in osteoarthritis rat model”. 7.4 (2019): 529.
33. Kuyinu EL., et al. “Animal models of osteoarthritis: classification, update, and measurement of outcomes”. 11.1 (2016): 1-27.
34. Zare R., et al. “Are Stem Cells Derived from Synovium and Fat Pad Able to Treat Induced Knee Osteoarthritis in Rats?” (2020).
35. Chen R., et al. “Attenuation of the progression of articular cartilage degeneration by inhibition of TGF-β1 signaling in a mouse model of osteoarthritis”. 185.11 (2015): 2875-2885.
36. Chen W., et al. “Conditioned medium of mesenchymal stem cells delays osteoarthritis progression in a rat model by protecting subchondral bone, maintaining matrix homeostasis, and enhancing autophagy”. 13.9 (2019): 1618-1628.
37. Salami A., et al. “An audit on the quality of intra-oral digital radiographs taken in a postgraduate Paediatric Dentistry setting”. 16.1 (2017): 1-4.
38. Beneteau B., et al. “Automated kinetic assay of angiotensin-converting enzyme in serum”. 32.5 (1986): 884-886.
39. Bijlsma JW., et al. “Osteoarthritis: an update with relevance for clinical practice”. 377.9783 (2011): 2115-2126.
40. Meirelles LdS., et al. “Mesenchymal stem cells reside in virtually all post-natal organs and tissues”. 119.11 (2006): 2204-2213.
41. Chen Y-C., et al. “Can mesenchymal stem cells and their conditioned medium assist inflammatory chondrocytes recovery?” 13.11 (2018): e0205563.
42. Tang Y., et al. “A comparative assessment of adipose‐derived stem cells from subcutaneous and visceral fat as a potential cell source for knee osteoarthritis treatment”. 21.9 (2017): 2153-2162.
43. Tanideh N., et al. “Paracrine Effect of Synovial-Derived Stem Cells on Induced Knee Osteoarthritis in Rats”. 22.6 (2021).
44. Price A., et al. “Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: in vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis”. 56.2 (2007): 441-447.
45. Zhang Y., et al. “Experimental study on repairing full-thickness cartilage defect of goat knee joint with human umbilical cord mesenchymal stem cells and acellular chondrocyte extracellular matrix oriented scaffold”. 6 (2016): 32-39.
46. Estakhri F., et al. “The effect of kaempferol and apigenin on allogenic synovial membrane-derived stem cells therapy in knee osteoarthritic male rats”. 27.3 (2020): 817-832.
47. Tanideh N., et al. “Hydroethanolic extract of Psidium guajava leaf for induced osteoarthritis using a guinea pig model”. 92.6 (2017): 417-424.
48. Tanideh N., et al. “The protective effects of grape seed oil on induced osteoarthritis of the knee in male rat models”. 15.1 (2020): 1-9.
49. Goebel JC., et al. “In vivo high-resolution MRI (7T) of femoro-tibial cartilage changes in the rat anterior cruciate ligament transection model of osteoarthritis: a cross-sectional study”. 49.9 (2010): 1654-1664.
50. Wu Y., et al. “Expressions of Renin, angiotensin converting enzyme, angiotensin receptor 1, and angiotensin receptor 2 in synovial tissue of osteoarthritis at different stages”. 34.3 (2020): 362-366.
51. Kaschina E and Unger TJBp. “Angiotensin AT1/AT2 receptors: regulation, signalling and function”. 12.2 (2003): 70-88.